Novel Coronavirus Breathalyzer Test Detects COVID-19 Non-Invasively in Seconds
By LabMedica International staff writers Posted on 26 Aug 2020 |
Novel Coronavirus Breathalyzer Test Detects COVID-19 Non-Invasively in Seconds (Photo courtesy of Technion)
A novel breathalyzer uses intelligent nanotechnology that is capable of rapidly detecting COVID-19 in exhaled breath and has “the potential to serve as a monitoring and epidemic control tool.”
A team of scientists from Technion - Israel Institute of Technology (Haifa, Israel) and Russell Berrie Nanotechnology Institute (Haifa, Israel), in collaboration with Chinese researchers, has devised a novel breath analyzer test to rapidly detect the disease caused by the novel coronavirus. The testing device is an intelligent nanotechnology that can rapidly detect COVID-19 from specific volatile organic compounds (VOCs) in exhaled breath.
The efficacy of the COVID-19 breath analyzer testing device, which is comprised of a nanomaterial-based sensor array, was successfully validated in March by a preliminary case-control clinical study in China. It can detect disease-specific biomarkers in exhaled breath with 92% accuracy, 100% sensitivity, and 84% specificity. While a larger cohort study is still needed to validate the results, the researchers envision the test’s utility as a screening tool for airports, shopping centers, and other public places where the risk of community spread is high.
The pre-screening diagnostic system could offer a screening solution that can be performed at home or point-of-care facilities, greatly reducing unneeded confirmatory tests and reducing the burden on hospitals. Importantly, the artificial intelligence of the device can be modified and applied to any other infectious diseases. The researchers believe that this approach can serve as a platform for a rapidly available diagnostic tool that can be used in the case of a new disease outbreak.
Related Links:
Technion – Israel Institute of Technology
Russell Berrie Nanotechnology Institute
A team of scientists from Technion - Israel Institute of Technology (Haifa, Israel) and Russell Berrie Nanotechnology Institute (Haifa, Israel), in collaboration with Chinese researchers, has devised a novel breath analyzer test to rapidly detect the disease caused by the novel coronavirus. The testing device is an intelligent nanotechnology that can rapidly detect COVID-19 from specific volatile organic compounds (VOCs) in exhaled breath.
The efficacy of the COVID-19 breath analyzer testing device, which is comprised of a nanomaterial-based sensor array, was successfully validated in March by a preliminary case-control clinical study in China. It can detect disease-specific biomarkers in exhaled breath with 92% accuracy, 100% sensitivity, and 84% specificity. While a larger cohort study is still needed to validate the results, the researchers envision the test’s utility as a screening tool for airports, shopping centers, and other public places where the risk of community spread is high.
The pre-screening diagnostic system could offer a screening solution that can be performed at home or point-of-care facilities, greatly reducing unneeded confirmatory tests and reducing the burden on hospitals. Importantly, the artificial intelligence of the device can be modified and applied to any other infectious diseases. The researchers believe that this approach can serve as a platform for a rapidly available diagnostic tool that can be used in the case of a new disease outbreak.
Related Links:
Technion – Israel Institute of Technology
Russell Berrie Nanotechnology Institute
Latest COVID-19 News
- New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
- Long COVID Etiologies Found in Acute Infection Blood Samples
- Novel Device Detects COVID-19 Antibodies in Five Minutes
- CRISPR-Powered COVID-19 Test Detects SARS-CoV-2 in 30 Minutes Using Gene Scissors
- Gut Microbiome Dysbiosis Linked to COVID-19
- Novel SARS CoV-2 Rapid Antigen Test Validated for Diagnostic Accuracy
- New COVID + Flu + R.S.V. Test to Help Prepare for `Tripledemic`
- AI Takes Guesswork Out Of Lateral Flow Testing
- Fastest Ever SARS-CoV-2 Antigen Test Designed for Non-Invasive COVID-19 Testing in Any Setting
- Rapid Antigen Tests Detect Omicron, Delta SARS-CoV-2 Variants
- Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study
- Set Up Reserve Lab Capacity Now for Faster Response to Next Pandemic, Say Researchers
- Blood Test Performed During Initial Infection Predicts Long COVID Risk
- Low-Cost COVID-19 Testing Platform Combines Sensitivity of PCR and Speed of Antigen Tests
- Finger-Prick Blood Test Identifies Immunity to COVID-19
- Quick Test Kit Determines Immunity Against COVID-19 and Its Variants